Position in NVS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$900,826
+$46,343 QoQ
Shares Held
5,748
+2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#658
of 1,603 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $28,490,833 across 13 Drug Manufacturers - General names. NVS ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,081 | $14,490,315 | |
| 2 | ABBV |
AbbVie Inc.
|
13,295 | $3,345,553 | |
| 3 | JNJ |
Johnson & Johnson
|
12,384 | $3,145,164 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,912 | $1,530,692 | |
| 5 | AMGN |
Amgen Inc
|
3,413 | $1,235,915 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,694 | $972,059 | |
| 7 | NVS |
Novartis AG
This page
|
5,748 | $900,826 | |
| 8 | PFE |
Pfizer Inc
|
36,772 | $885,469 |
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $900,826 | 5,748 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $854,483 | 5,594 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $871,476 | 6,321 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $926,149 | 7,222 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $724,244 | 5,985 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $665,981 | 5,974 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $609,647 | 6,265 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $658,834 | 5,728 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $599,369 | 5,630 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $448,343 | 4,635 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $378,738 | 3,751 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $389,716 | 3,826 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $353,891 | 3,507 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $412,252 | 4,481 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $283,590 | 3,126 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $304,344 | 4,004 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $224,427 | 2,655 | Shares | Sole | 2022-08-02 | |
| 2020-06-30 | $853,224 | 9,769 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $805,618 | 9,771 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||